Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Study ID: NCT06186401
Start Date: 2024-04-30
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

E-SYNC T Cells

Cyclophosphamide (non-investigational)

Fludarabine (non-investigational)

Leukapheresis

Surgical resection

Sponsor

Hideho Okada, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list

Preoperative Irradiation for Stage I Breast Cancer

Study ID: NCT05464667
Start Date: 2023-07-07
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Radiation Therapy (RT)

Sponsor

Barry hair

Source: clinicaltrials.gov

Share:
Add to list

Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma

Study ID: NCT05660967
Start Date: 2023-03-06
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

Epcoritamab

Lenalidomide

Sponsor

Genmab

Source: clinicaltrials.gov

Share:
Add to list

TmPSMA-02 in mCRPC

Study ID: NCT06046040
Start Date: 2024-01-31
End Date: 2042-01-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

TmPSMA-02 CAR T Cells

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Study ID: NCT06377540
Start Date: 2024-12-04
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

Pembrolizumab

Autologous stem cell transplant

Carmustine

Etoposide

Cytarabine

Melphalan

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Induction FLOT with CROSS CRT for Esophageal Cancer

Study ID: NCT04028167
Start Date: 2020-04-08
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Sequential FLOT followed by chemoradiation

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Study ID: NCT05537740
Start Date: 2022-10-11
End Date: 2027-05-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

354

Intervention / Treatment

I have a rhythm

Pembrolizumab

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Study ID: NCT06876662
Start Date: 2025-05-20
End Date: 2032-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

279

Intervention / Treatment

Pester

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

Met Non Small Cell Cancer Registry (MOMENT)

Study ID: NCT05376891
Start Date: 2022-10-04
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment
Sponsor

EMD Serono Research & Development Institute, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Study ID: NCT05411094
Start Date: 2023-05-22
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Durvalumab

Flapberry

Radiation Therapy

Radiologic Examination

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list